An Exploratory Clinical Trial Evaluating LX109 Gene Therapy in Patients With nAMD

NCT06022744 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

To Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD

Interventions

DRUG: LX109

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine